Regenerative discovery
EVs and enabling platforms for researchers studying regeneration and tissue biology.
GENEFRONT · EXTRACELLULAR VESICLE SCIENCE
EV production.
New possibilities.
From human iPSC and MSC sources to engineered EVs and sustained-release formulations. Built to support regenerative discovery.
EXTRACELLULAR VESICLE · ILLUSTRATIVE VISUALIZATION
iPSC + MSCEV source-cell platforms
Optimizedmedia and production processes
EngineeredEVs and sustained-release formulations
PRODUCTION AT THE CORE
Start with the cell.
Expand the potential.
GeneFront produces extracellular vesicles from sources including human induced pluripotent stem cells (iPSCs) and mesenchymal stromal cells (MSCs).
Our optimized production processes and proprietary culture media are developed to increase EV production capacity. We also engineer EVs and develop sustained-release formulations to support biomolecule delivery research.
Discover our platformsOUR CORE PLATFORMS
Produce. Engineer. Deliver.
EV production is the foundation. Engineering and sustained-release formulations extend what researchers can investigate.
Built from the source.
Human iPSC- and MSC-derived EVs, optimized production processes, and proprietary culture media developed to increase production capacity.
Explore EV production02 / EV ENGINEERING
Shape the next research question.
Engineered EVs for biomolecule delivery research, guided by cargo, target organ, and intended application.
03 / SUSTAINED RELEASEExplore delivery over time.
GeneFront-developed EV formulations for sustained release and research into longer-term, organ-targeted biomolecule delivery.
WHERE THE WORK CAN LEAD
A foundation for regenerative discovery.
Supporting researchers today while developing EV platforms for future therapeutic, diagnostic, and cosmetic applications.
Therapeutic development
Research into engineered EVs and delivery of biomolecules for future therapeutic applications.
Diagnostic research
EV-associated molecular signals and cell-specific capture tools for disease-related research.
Cosmetic applications
EV formulation development for skin, scalp, and cosmetic research.
ONE PLATFORM IN THE PORTFOLIO
EVHook: cell-specific capture.
One cell type per 96-well plate. Choose from 12 target cell types, or discuss a custom plate for your chosen cell type.
TWO PATHS. ONE SCIENTIFIC FOUNDATION.
Build a study.
Build a collaboration.
01
For researchers & biotech teams
Discuss EV source cells, production, engineering, and formulation needs for your regenerative discovery work.
Discuss your EV project02
For partners & investors
Explore the EV platform, development priorities, and opportunities for research collaboration, licensing, or strategic investment discussions.
Explore partnershipsSTART A CONVERSATION
Let’s move your next question forward.
Connect with GeneFront about products, technical information, research collaborations, or investment and partnership discussions.